Elsevier

Clinical Immunology

Volume 220, November 2020, 108591
Clinical Immunology

Review Article
On the genetics and immunopathogenesis of COVID-19

https://doi.org/10.1016/j.clim.2020.108591Get rights and content

Highlights

  • Severe COVID-19 is not a consequence of excessive viral burden

  • Severe COVID-19 is an autoinflammatory disease

  • The adaptive immune system is not a defense organization

Abstract

Most severe cases with COVID-19, especially those with pulmonary failure, are not a consequence of viral burden and/or failure of the ‘adaptive’ immune response to subdue the pathogen by utilizing an adequate ‘adaptive’ immune defense. Rather it is a consequence of immunopathology, resulting from imbalanced innate immune response, which may not be linked to pathogen burden at all. In fact, it might be described as an autoinflammatory disease. The Kawasaki-like disease seen in children with SARS-CoV-2 exposure might be another example of similar mechanism.

Keywords

SARS-CoV-2
Coronavirus
Immune response
Innate immunity
Kawasaki disease
Cytokine

Abbreviations

CoV
coronavirus
SARS-CoV-2
Severe Acute Respiratory Syndrome Coronavirus 2
COVID-19
coronavirus disease 2019
MERS
Middle East Respiratory Syndrome
ACE2
angiotensin converting enzyme 2
ADE
antibody dependent enhancement
ARDS
Acute Respiratory Disease Syndrome
TLR
Toll-like receptor
CRS
Cytokine Release Syndrome
IFN
type I/III interferons
SNP
single nucleotide polymorphism
GWAS
genome wide association study
Ab
antibody
NET
neutrophil extracellular trap

Cited by (0)

View Abstract